Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA’s Hand-Held Rx Counterfeit Detector Could Roll Out To Developing Nations

Executive Summary

Agency meets with USAID stakeholders and wants to maximize the public health impact of its hand-held counterfeit drug detection device, which allows for quick preliminary screening of drug shipments to determine if counterfeit or adulterated product is present.


Related Content

Gottlieb Showing Capitol Hill Skills With Funding Success
Track-and-Trace Law: Push Begins For 2015 Exchange Standards
FDA Counterfeit Screening Tool Gets Field Test In Ghana; Corning Prepares Device For Mass Production
FDA’s Rx Administrative Detention Reg Coming, But Not For A Little While
FDASIA Is Signed, Not That White House Wanted Anyone To Notice
Track-and-Trace Deal’s Failure Leaves California In Control Of Agenda
Track And Trace Negotiations Continue As Senate Works To Cull Amendments
Foreign Regulatory Systems Can Be Strengthened By Receiving FDA Inspection Data, IOM Says
FDA Envisions Many Regulatory Coalitions Dealing With Globalization Issues





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts